Anbio Biotechnology annual operating margin
2022
2023
2024
2025
Anbio Biotechnology's operating margin was 66.70% for fiscal 2025.
View full Anbio Biotechnology company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 66.70% | +42.33 pp |
| 2024 | 2024-12-31 | 24.38% | −4.84 pp |
| 2023 | 2023-12-31 | 29.22% | −14.09 pp |
| 2022 | 2022-12-31 | 43.30% | — |
Between the periods ended 2022-12-31 and 2025-12-31, Anbio Biotechnology's operating margin increased from 43.30% to 66.70%, a change of +23.40 percentage points.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Anbio Biotechnology source filings ↗